The effect of stercuronium on cardiac muscarinic receptors.
D000109:Acetylcholine / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000494:pharmacology; D000470:Alkaloids; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002802:Cholinesterases / Q000378:metabolism; D004347:Drug Interactions; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D066298:In Vitro Techniques; D008688:Methacholine Compounds / Q000494:pharmacology; D009206:Myocardium / Q000201:enzymology; D009466:Neuromuscular Blocking Agents / Q000494:pharmacology*; D010862:Pilocarpine / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D011245:Pregnadienes / Q000494:pharmacology*; D011759:Pyrrolidines / Q000494:pharmacology; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*; D014326:Tropanes / Q000494:pharmacology
D000470:Alkaloids; D008688:Methacholine Compounds; D009466:Neuromuscular Blocking Agents; D011245:Pregnadienes; D011759:Pyrrolidines; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D014326:Tropanes; D010862:Pilocarpine; D000255:Adenosine Triphosphate; D002217:Carbachol; D002802:Cholinesterases; D000109:Acetylcholine; D011188:Potassium; C003344:stercuronium